phase readout
saveNCT06360588: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm
view source ↗
comments(0)
5-min edit window · permanent after that